Novartis Share Price Rises on Upgraded Outlook and $15 Billion Buyback Announcement

Novartis raised its full-year outlook and announced a $15 billion share buyback program.
The company's share price climbed after the positive news, indicating investor confidence.
Novartis sales are now expected to rise high single digits percent and core operating income to grow double digits.
The buyback suggests Novartis is more likely to pursue small acquisitions over large deals.
Novartis posted strong Q2 results, beating earnings and revenue estimates on growth in innovative and generic medicines.